MoneyWorks4Me

Pharmaids Pharma - Quaterly Results

09 Nov 2021 Evaluate
The Sales for the quarter ended September 2021 of Rs. 5.71 million declined by -82.46% from Rs. 32.56 millions.Net profit for the quarter ended September 2021 increased significantly by 86.84% to Rs. 0.71 millions from Rs. 0.38 millions.Operating profit surged to 0.76 millions from the corresponding previous quarter of 0.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 5.71 32.56 -82.46 29.12 32.56 -10.57 85.51 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.26 0.00 0.26 0.00 0.00
PBIDT 0.76 0.60 26.67 1.22 0.74 64.86 1.33 -3.36 -139.58
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
PBDT 0.76 0.60 26.67 1.22 0.74 64.86 1.33 -3.37 -139.47
Depreciation 0.04 0.11 -63.64 0.08 0.22 -63.64 0.45 0.39 15.38
PBT 0.72 0.49 46.94 1.14 0.52 119.23 0.88 -3.76 -123.40
TAX 0.01 0.11 -90.91 0.33 0.11 200.00 -0.05 -4.09 -98.78
Deferred Tax 0.01 0.00 0.00 0.33 0.00 0.00 -0.05 -4.09 -98.78
PAT 0.71 0.38 86.84 0.81 0.41 97.56 0.93 0.33 181.82
Equity 102.69 102.69 0.00 103.11 103.11 0.00 102.69 102.69 0.00
PBIDTM(%) 13.31 1.84 622.27 4.19 2.27 84.34 1.56 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..